“Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated With Pembrolizumab”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): 2006–2010. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/2837.